Emily A. Rhoads, PA-C

Emily Rhoads practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Emily Rhoads' NPI, 1730492935, was assigned on July 16, 2010. Emily Rhoads holds California license 20956.

Emily Rhoads' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Emily Rhoads' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Emily Rhoads is also affiliated with UW Health SwedishAmerican Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Emily Rhoads to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Rhoads practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Emily Rhoads' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Emily Rhoads is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Emily Rhoads' licenses on file in 2 states: California and Arizona.

Dmand AI lists fibromyalgia and chronic pain, lower back pain, neck pain and spine problems, scoliosis, thoracic spine disorders and tobacco use among the conditions Emily Rhoads treats.

CMS data shows 271 Medicare services from Emily Rhoads across 8 procedure codes in 2024, for 231 Medicare patients. Medicare paid $19,868 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Emily Rhoads in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have arthritis, and 72% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Emily Rhoads' median patient age at 69, with 54% women.

In 2024, Emily Rhoads wrote 101 Medicare Part D claims for 55 patients. 94% of them were for generic drugs. CMS names the drug for 61 of them, across 3 drugs with 11 or more claims each, at $829 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Emily Rhoads for performance year 2024, reported as part of a group. Emily Rhoads accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Emily Rhoads from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $44.